secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K/A
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001437749-23-031978
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva Pharmaceuticals completes auditor change to Moss Adams LLP effective Nov 14, 2023
--------------------------------------------------------------------------------

- Armanino LLP's engagement ended Nov 14, 2023 after completing Q3 2023 review; Moss Adams LLP engaged same day.
- Armanino's 2022 audit report included a going concern explanatory paragraph; no disagreements or reportable events.
- Moss Adams was not consulted on accounting principles or audit opinion prior to engagement.
- Auditor change previously disclosed Oct 4, 2023; this amendment adds effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/0001437749-23-031978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923031978/rvph20231108_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-031978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer